Hester Biosciences Ltd posts drop in Q4 FY23 consolidated net profit to Rs. 4.53 crores

Hester Biosciences Limited has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 70.487 crores during the period ended March 31, 2023 as compared to Rs. 79.335 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 4.531 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 11.186 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 6.72 for the period ended March 31, 2023 as compared to Rs. 14.29 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹70.487 crs	₹79.335 crs	-11.15%
Net Profit	₹4.531 crs	₹11.186 crs	-59.49%
EPS	₹6.72	₹14.29	-52.97%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.70.487 crores during the period ended March 31, 2023 as compared to Rs.63.661 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.4.531 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.7.723 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.6.72 for the period ended March 31, 2023 as compared to Rs.10.59 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹70.487 crs	₹63.661 crs	10.72%
Net Profit	₹4.531 crs	₹7.723 crs	-41.33%
EPS	₹6.72	₹10.59	-36.54%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.281.242 crores during the Financial Year ended March 31, 2023 as compared to Rs.248.747 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.26.627 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.39.320 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.32.96 for the Financial Year ended March 31, 2023 as compared to Rs.46.41 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹281.242 crs	₹248.747 crs	13.06%
Net Profit	₹26.627 crs	₹39.320 crs	-32.28%
EPS	₹32.96	₹46.41	-28.98%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 1831.40 as compared to the previous close of Rs. 1824.15. The total number of shares traded during the day was 195 in over 86 trades.

The stock hit an intraday high of Rs. 1870.00 and intraday low of 1801.00. The net turnover during the day was Rs. 358294.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q4FY23 FY2023 ResultUpdate